“Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC” was accepted as one of this year’s BEST presentations submitted for Clinical Oncology at EANM15
CNR Ibb | back to homepage
CNR Ibb | back to homepage